"Pharmaceutical and Clinical Research SMO"

During the past decade, Next Phase Research Alliance conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Next Phase Research Alliance" are "Pneumococcal Disease" (1 trials) and "Pneumococcal Infections" (1 trials). Many other conditions were trialed in "Next Phase Research Alliance" in a lesser frequency.

Most popular intervention types in "Next Phase Research Alliance" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Multivalent" (1 trials) and "Prevnar 13" (1 trials). Other intervention names were less common.

The vast majority of trials in "Next Phase Research Alliance" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Next Phase Research Alliance". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Next Phase Research Alliance, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Next Phase Research Alliance, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".